NASDAQ:ANTH

Anthera Pharmaceuticals Stock Signals

etoro logo Buy ANTH
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 31, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Anthera Pharmaceuticals Inc

General

Signal Type Signal Value Data
Score 0.000 133 days ( -9,900.00 %
Last Price $0.0001 0 %
Performance History
7 Days
$0.0001 $0.0001
0%
30 Days
$0.0010 $0.0001
-90.00%
12 Mos
$0.0001 $0.0001
0%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 35.14
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0001 - $0.0001
Trend - 3 mos 69.07 % High Width: 526.55 %
Pred. range - 3 mos $0.0003 - $0.0018 Low 191.30 % - 1,725.14 %
Volume Direction Sell High Volume: 11 · Direction: 0
Pivot Short Buy Very Low Jul 17, 2026 - 11 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Jul 16, 2026 - 12 days
Short/Long MA 3 mos Sell Medium Jul 17, 2026 - 11 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 45.67
Signal Type Signal Value Importance Data
Trend - 12 mos 45.59 % Very High Width: 1,046.49 %
Pred. range - 12 mos $0.0002 - $0.0019 High 70.01 % - 1,849.15 %
Short MA 12 mos Sell Very High Jan 13, 2026 - 138 days
Long MA 12 mos Sell Very High Jul 16, 2026 - 12 days
Short/Long MA 12 mos Buy Very High Apr 02, 2026 - 83 days
Pivot Long Buy Low Jul 17, 2026 - 11 days
RSI Long Pivot Signal Sell Low Nov 30, -0001 - N/A days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ANTHERA PHARMACEUTICALS INC
Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE